"97: Converting from Paricalcitol Injection to Doxercalciferol Capsules in CKD Patients on HD: A Randomized, Open-Label Study to Determine Clinically Appropriate Doses" by J. Hertel

Selected Works of Srinivas Hariachar, MD

Article

97: Converting from Paricalcitol Injection to Doxercalciferol Capsules in CKD Patients on HD: A Randomized, Open-Label Study to Determine Clinically Appropriate Doses

American Journal of Kidney Diseases (2008)

J. Hertel, Nephrology Associates, Augusta GA
S. Hariachar, Outcomes Research International, Hudson, FL
A. Gonzalez, Renal Endocrine Associates, P.C., Pittsburgh, PA

Link

Disciplines

Medicine and Health Sciences and
Urology

Publication Date

April 1, 2008

DOI

10.1053/J.AJKD.2008.02.105

Citation Information

J. Hertel, S. Hariachar and A. Gonzalez. "97: Converting from Paricalcitol Injection to Doxercalciferol Capsules in CKD Patients on HD: A Randomized, Open-Label Study to Determine Clinically Appropriate Doses" American Journal of Kidney Diseases Vol. 51 Iss. 4 (2008)
Available at: http://works.bepress.com/srinivas-hariachar/4/